Non Applicability of Annual Secretarial Compliance Report for the year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals Ltd has informed BSE that it is not required to file the Annual Secretarial Compliance Report for the financial year ended March 31, 2025. Under SEBI's Listing Regulations, companies listed on the SME segment are exempt from this requirement. The company is listed on the SME platform of BSE (Scrip Code: 539680), so the exemption applies. This is a routine regulatory disclosure confirming the company's small-cap, SME-listed status.
No material impact on shareholders or stock price. This is a routine procedural filing that simply confirms the company qualifies for an exemption based on its SME listing status.